Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Average Rating of Hold by Brokerages

Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Get Rating) have received a consensus recommendation of “Hold” from the eight ratings firms that are currently covering the firm, Marketbeat.com reports. Five research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1 year price […]

Related Keywords

Piper Sandler ,Jpmorgan Chase Co ,Rigel Pharmaceuticals Stock Performance ,Citigroup ,Rigel Pharmaceuticals Company Profile ,Analyst Recommendations For Rigel Pharmaceuticals ,Rigel Pharmaceuticals ,Geode Capital Management ,Nasdaq ,Putnam Investments ,News Ratings For Rigel Pharmaceuticals Daily ,Rigel Pharmaceuticals Inc ,Get Rating ,Street Group ,Street Corp ,Capital Management ,Rigel Pharmaceuticals Daily ,